Improved Oral Anticoagulation After a Dietary Vitamin K-Guided Strategy A Randomized Controlled Trial

被引:35
|
作者
de Assis, Michelli C. [1 ]
Rabelo, Eneida R. [1 ]
Avila, Christiane W. [1 ]
Polanczyk, Carisi Anne [1 ]
Rohde, Luis E. [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Serv Cardiol,Div Cardiovasc, Postgrad Program Cardiol & Cardiovasc Sci, BR-90035003 Porto Alegre, RS, Brazil
关键词
anticoagulants; diet; vitamin K; INTRACRANIAL HEMORRHAGE; RISK-FACTORS; WARFARIN; SENSITIVITY; SUPPLEMENTATION; VARIABILITY; STABILITY;
D O I
10.1161/CIRCULATIONAHA.109.849208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Dietary vitamin K is thought to be an important factor that interferes with anticoagulation stability, but the clinical applicability of this interaction has not been evaluated adequately in prospective studies. Methods and Results-In a randomized controlled trial that enrolled outpatients with a recent international normalized ratio (INR) outside the therapeutic target, we compared 2 strategies to optimize long-term oral anticoagulation: (1) a conventional approach based on changes in anticoagulant prescription and (2) a dietary vitamin K- guided strategy based on simple modifications of the amount of vitamin K- rich foods ingested per week. The primary efficacy end point was the percentage of patients who achieved a prespecified INR target at 90 days after randomization. Study population (n = 132) predominantly included men with mechanical heart prostheses (58%) or atrial fibrillation (35%). Over time, patients allocated to the vitamin K- guided strategy reached the prespecified INR more frequently so that after 90 days of follow-up, 74% were on target compared with 58% of patients managed conventionally (P = 0.04). Patients allocated to the dietary vitamin K- guided strategy had the same magnitude and direction of INR variation as those observed with the conventional approach in the short term (15 days) for both underanticaogulated and overanticoagulated patients. Minor bleeding or use of parenteral vitamin K were also marginally less frequent in patients managed according to the dietary intervention (1 [1.5%] versus 7 [11%]; P = 0.06). Conclusions-A vitamin K-guided management strategy to adjust long-term oral anticoagulation is feasible and safe and may result in an increased chance of reaching target levels of INR. (Circulation. 2009; 120: 1115-1122.)
引用
收藏
页码:1115 / U143
页数:11
相关论文
共 50 条
  • [1] Treatment of excessive anticoagulation due to warfarin with oral vitamin K: A randomized controlled trial.
    Crowther, MA
    Julian, J
    McCarty, D
    Douketis, JD
    Kovacs, M
    Biagoni, L
    Schnurr, T
    McGinnis, J
    Gent, M
    Hirsh, J
    Ginsberg, JS
    BLOOD, 2000, 96 (11) : 450A - 450A
  • [2] Dietary vitamin K guidance: an effective strategy for stable control of oral anticoagulation?
    Booth, Sarah L.
    NUTRITION REVIEWS, 2010, 68 (03) : 178 - 181
  • [3] Role of dietary vitamin K intake in chronic oral anticoagulation: Prospective evidence from observational and randomized protocols
    Franco, V
    Polanczyk, CA
    Clausell, N
    Rohde, LE
    AMERICAN JOURNAL OF MEDICINE, 2004, 116 (10): : 651 - 656
  • [4] Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation
    Patel, RJ
    Witt, DM
    Saseen, JJ
    Tillman, DJ
    Wilkinson, DS
    PHARMACOTHERAPY, 2000, 20 (10): : 1159 - 1166
  • [5] Dietary vitamin K-1 and stability of oral anticoagulation: Proposal of a diet with constant vitamin K-1 content
    Booth, SL
    Charnley, JM
    Sadowski, JA
    Saltzman, E
    Bovill, EG
    Cushman, M
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (03) : 504 - 509
  • [6] Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: A randomized controlled trial
    Ageno, W
    Crowther, M
    Steidl, L
    Ultori, C
    Mera, V
    Dentali, F
    Squizzato, A
    Marchesi, C
    Venco, A
    THROMBOSIS AND HAEMOSTASIS, 2002, 88 (01) : 48 - 51
  • [7] Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation -: A prospective randomized controlled study
    Lubetsky, A
    Yonath, H
    Olchovsky, D
    Loebstein, R
    Halkin, H
    Ezra, D
    ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (20) : 2469 - 2473
  • [8] Oral vitamin A for the treatment of chronic radiation proctopathy: A randomized, controlled trial
    Levitsky, J
    Ehrenpreis, ED
    Jani, AB
    Ahn, J
    Hong, JJ
    GASTROENTEROLOGY, 2003, 124 (04) : A64 - A64
  • [9] Effect of 200 μG/day of vitamin k1 on the variability of anticoagulation control in patients on warfarin: A randomized controlled trial
    Majeed, Habeeb
    Rodger, Marc
    Forgie, Melissa
    Carrier, Marc
    Taljaard, Monica
    Scarvelis, Dimitrios
    Gonsalves, Carol
    Rodriguez, Rosendo A.
    Wells, Philip S.
    THROMBOSIS RESEARCH, 2013, 132 (03) : 329 - 335
  • [10] Self-management of oral anticoagulation in the elderly: Rationale, design, baselines and oral anticoagulation control after one year of follow-up - A randomized controlled trial
    Siebenhofer, Andrea
    Rakovac, Ivo
    Kleespies, Caroline
    Piso, Brigitte
    Didjurgeit, Ulrike
    THROMBOSIS AND HAEMOSTASIS, 2007, 97 (03) : 408 - 416